RAS-driven cancers | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

97,131 results for “RAS-driven cancers”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Rechallenge With Panitumumab Driven by RAS Dynamic of Resistance

32 participants · First posted Jul 24, 2017

Studying Pathways of Resistance in KRAS-driven Cancers

58 participants · First posted Mar 9, 2022

Active, not recruiting

Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial

199 participants · First posted Sep 26, 2022

A Trial of mFOLFIRI With MEK162 in Patients With Advanced RAS (HRAS, NRAS, or KRAS) Positive Metastatic Colorectal Cancers

25 participants · First posted Nov 24, 2015

Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer

First posted May 3, 2021

Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers

19 participants · First posted Jun 23, 2010

Not yet recruiting

A Study of AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression

228 participants · First posted Jul 7, 2026

Active, not recruiting

Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers

21 participants · First posted Jan 3, 2023

A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers

360 participants · First posted May 21, 2024

Not yet recruiting

Testing the Addition of an Anti-Cancer Drug, Daraxonrasib, for Relapsed or Refractory Solid Tumors With RAS Mutations

77 participants · First posted Sep 15, 2026

Page 1 of 7812